Robert H. Gruninger

895 citations
14 papers · 740 · h-index 14

Impact in

    • Synthesis and biological activity
    • Synthesis and Characterization of Heterocyclic Compounds
    • Synthesis and Biological Evaluation
    • Click Chemistry and Applications
  • Oncology top 10%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research

Papers in

    • Cancer-related Molecular Pathways 5
    • HER2/EGFR in Cancer Research 4
    • Click Chemistry and Applications 3

Robert H. Gruninger

14 papers receiving 722 citations

Peers

Robert H. Gruninger
Comparison fields: 5 of 76
  • Organic Chemistry 352
  • Oncology 226
  • Toxicology 22
  • Cell Biology 79
  • Computational Theory and Mathematics 78
Replace Mauro Angiolini with:
Mauro Angiolini Italy
Karen L. Milkiewicz United States
Venkat R. Pallela United States
Pascal Furet Switzerland
Brendan Frett United States
Renaud Prudent France
Angel R. Fuentes‐Pesquera United States
Bernard Barlaam United Kingdom
Qingjie Ding China
Rémy Morgentin France
Robert H. Gruninger relative to Mauro Angiolini Italy Mauro Angiolini's profile →
Citations per field
00.5×1.5×1.9×
Mauro Angiolini · 1×
Citations per year

Countries citing papers authored by Robert H. Gruninger

Since Specialization
Citations

This map shows the geographic impact of Robert H. Gruninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Gruninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Gruninger more than expected).

Fields of papers citing papers by Robert H. Gruninger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Gruninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Gruninger. The network helps show where Robert H. Gruninger may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert H. Gruninger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert H. Gruninger Line = papers co-authored together Robert H. Gruninger links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 2005114
2 2005107
3 200881
4 200580
5 200775
6 199652
7 200849
8 200741
9 200531
10 200731
11 200428
12 200522
13 199716
14 200713

About Robert H. Gruninger

Robert H. Gruninger is a scholar working on Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 14 papers that have together received 740 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Click Chemistry and Applications (3 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Mechanisms and Therapy (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Organic Chemistry (352 citations), Oncology (226 citations), Toxicology (22 citations), Cell Biology (79 citations) and Computational Theory and Mathematics (78 citations). Robert H. Gruninger has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Steven A. Middleton, Angel R. Fuentes‐Pesquera, Stuart L. Emanuel, Peter J. Connolly, Linda K. Jolliffe, Ronghui Lin, Catherine A. Rugg, Steven K. Wetter, William V. Murray and Mary Adams. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, Cancer Research and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact